[
  {
    "ts": "2025-10-20T11:00:00+00:00",
    "headline": "CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology",
    "summary": "CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen), today announced positive results from a head-to-head comparative study of its rhCollagen-based bioink, Collink.3D™, and Matrigel®, conducted by the Levenberg Lab at Technion - Israel Institute of Technology.",
    "url": "https://finance.yahoo.com/news/collplants-rhcollagen-based-bioink-demonstrates-110000723.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "0ded1ec3-3bea-3b4b-a107-2993c28b6b0a",
      "content": {
        "id": "0ded1ec3-3bea-3b4b-a107-2993c28b6b0a",
        "contentType": "STORY",
        "title": "CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology",
        "description": "",
        "summary": "CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen), today announced positive results from a head-to-head comparative study of its rhCollagen-based bioink, Collink.3D™, and Matrigel®, conducted by the Levenberg Lab at Technion - Israel Institute of Technology.",
        "pubDate": "2025-10-20T11:00:00Z",
        "displayTime": "2025-10-20T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f6b78f41766e2115698eac1e909a1957",
          "originalWidth": 400,
          "originalHeight": 196,
          "caption": "Collink.3D (left image) exhibited skeletal Muscle elongation while Matrigel (right image) appeared non-uniform on day 7 (Technion)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/46whGI6wXO21K73xdatxFQ--~B/aD0xOTY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f6b78f41766e2115698eac1e909a1957.cf.webp",
              "width": 400,
              "height": 196,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SqwndgP7bc3DQXCy06Z68g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f6b78f41766e2115698eac1e909a1957.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/collplants-rhcollagen-based-bioink-demonstrates-110000723.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/collplants-rhcollagen-based-bioink-demonstrates-110000723.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CLGN"
            },
            {
              "symbol": "GLW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]